Professor Carmel Hawley
Professor

Carmel Hawley

Email: 

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

721 works between 1965 and 2025
All (721) Journal Article (490) Conference Publication (225) Book Chapter (6)

361 - 380 of 721 works

2015

Journal Article

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial

Johnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015). A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 (1), 49-57. doi: 10.1053/j.ajkd.2014.06.020

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial

2015

Conference Publication

Scope and consistency of outcomes reported in randomised trials of haemodialysis

Williams, G. J., Tong, A., Manns, B., Hemmelgarn, B., Wheeler, D. C., Tugwell, P., Winkelmayer, W. C., Van Biesen, W., Kerr, P. G., Polkinghorne, K. R., Howard, K., Pollock, C., Hawley, C. M., Johnson, D. W., Mcdonald, S. P., Gallagher, M. P., Urquhart-Secord, R. and Craig, J. C. (2015). Scope and consistency of outcomes reported in randomised trials of haemodialysis. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, ACT Australia, 7-9 September 2015. HOBOKEN: WILEY-BLACKWELL.

Scope and consistency of outcomes reported in randomised trials of haemodialysis

2014

Journal Article

The association between body mass index and mortality in incident dialysis patients

Badve S.V., Paul S.K., Klein K., Clayton P.A., Hawley C.M., Brown F.G., Boudville N., Polkinghorne K.R., McDonald S.P. and Johnson D.W. (2014). The association between body mass index and mortality in incident dialysis patients. PLoS ONE, 9 (12) e114897, 1-13. doi: 10.1371/journal.pone.0114897

The association between body mass index and mortality in incident dialysis patients

2014

Journal Article

End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases

Mallett, Andrew, Tang, Wen, Clayton, Philip A., Stevenson, Sarah, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Campbell, Scott B. and Johnson, David W. (2014). End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases. Nephrology Dialysis Transplantation, 29 (12), 2277-2286. doi: 10.1093/ndt/gfu254

End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases

2014

Journal Article

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Clayton, Philip and Johnson, David W. (2014). Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. Nephrology, Dialysis, Transplantation, 29 (10), 1940-1947. doi: 10.1093/ndt/gfu050

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis

2014

Conference Publication

Global longitudinal strain as an important predictor of cardiovascular and all-cause mortality in advanced chronic kidney disease

Stanton, T., Krishnasamy, R., Isbel, N. M., Hawley, C. M., Burrage, M., Leano, R., Haluska, B. A. and Marwick, T. H. (2014). Global longitudinal strain as an important predictor of cardiovascular and all-cause mortality in advanced chronic kidney disease. Congress of the European-Society-of-Cardiology (ESC), Barcelona Spain, Aug 30-Sep 03, 2014. Oxford: Oxford University Press.

Global longitudinal strain as an important predictor of cardiovascular and all-cause mortality in advanced chronic kidney disease

2014

Journal Article

Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study

Rossi, M., Campbell, K., Johnson, D., Stanton, T., Pascoe, E., Hawley, C., Dimeski, G., McWhinney, B., Ungerer, J. and Isbel, N. (2014). Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study. Nutrition, Metabolism and Cardiovascular Diseases, 24 (9), 1035-1042. doi: 10.1016/j.numecd.2014.04.006

Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study

2014

Journal Article

Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials

Wang, Amanda Y., Ninomiya, Toshiharu, Al-Kahwa, Anas, Perkovic, Vlado, Gallagher, Martin P., Hawley, Carmel and Jardine, Meg J. (2014). Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. American Journal of Kidney Diseases, 63 (6), 968-978. doi: 10.1053/j.ajkd.2014.01.435

Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials

2014

Journal Article

A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients

Campbell, Katrina L., Johnson, David W., Bauer, Judith, Hawley, Carmel M., Isbel, Nicole M., Stowasser, Michael, Whitehead, Jonathan P., Dimeski, Goce and McMahon, Emma (2014). A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrology, 15 (1) 57, 57.1-57.6. doi: 10.1186/1471-2369-15-57

A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients

2014

Journal Article

Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant

Stevenson, Sarah, Mallett, Andrew, Oliver, Kimberley, Hyland, Valentine, Hawley, Carmel, de Malmanche, Theo and Isbel, Nicole (2014). Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant. Nephrology, 19 (S1), 22-26. doi: 10.1111/nep.12195

Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant

2014

Journal Article

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis

Tang, Wen, Cho, Yeoungjee, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2014). The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 34 (2), 219-226. doi: 10.3747/pdi.2012.00318

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis

2014

Journal Article

Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis

Bose, Bhadran, Badve, Sunil V., Hiremath, Swapnil S., Boudville, Neil, Brown, Fiona G., Cass, Alan, De Zoysa, Janak R., Fassett, Robert G., Faull, Randall, Harris, David C., Hawley, Carmel M., Kanellis, John, Palmer, Suetonia C., Perkovic, Vlado, Pascoe, Elaine M., Rangan, Gopala K., Walker, Robert J., Walters, Giles and Johnson, David W. (2014). Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrology Dialysis Transplantation, 29 (2), 406-413. doi: 10.1093/ndt/gft378

Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis

2014

Journal Article

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

Cho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

2014

Journal Article

Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review

Muir, Christopher A., Kotwal, Sradha S., Hawley, Carmel M., Polkinghorne, Kevan, Gallagher, Martin P., Snelling, Paul and Jardine, Meg J. (2014). Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review. Clinical Journal of the American Society of Nephrology, 9 (1), 110-119. doi: 10.2215/CJN.03930413

Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review

2014

Conference Publication

Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients

Mallett, A., Campbell, S., Van Eps, C., Hawley, C., Burke, J., Hughes, P., Kausman, J., Hewitt, I., Parnham, A., Szer, J., Tuckfield, A., Payne, S., Young, J. and Isbel, N. (2014). Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients. WILEY-BLACKWELL.

Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients

2014

Conference Publication

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

Rossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Pascoe, E. M., Hawley, C. M., Dimeski, G., Mcwhinney, B. C., Ungerer, J. P. and Isbel, N. M. (2014). Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. HOBOKEN: Wiley.

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

2014

Conference Publication

Research priorities in chronic kidney disease: a priority setting partnership

Tong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Research priorities in chronic kidney disease: a priority setting partnership

2014

Conference Publication

LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY

Doucet, B., Kostner, K., Hawley, C. and Isbel, N. (2014). LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY. WILEY-BLACKWELL.

LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY

2014

Journal Article

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

Morrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

2014

Conference Publication

Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5

Krisnasamy, R., Isbel, N. M., Johnson, D. W., Campbell, S. B., Mudge, D. W., Van Eps, C. L., Fiumara, F., Bolwell, J., Stanton, T. and Hawley, C. M. (2014). Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourme, VIC Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2012
    A randomised placebo-controlled trial of Oxpentifylline (Trental) in erythropoietin-resistant anaemia (ERA) in chronic kidney disease
    The Roche Foundation for Anemia Research
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au